Merdad Parsey - Jun 13, 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chief Medical Officer
Signature
/s/ Edward S. Son by Power of Attorney for Merdad Parsey
Stock symbol
GILD
Transactions as of
Jun 13, 2023
Transactions value $
-$114,197
Form type
4
Date filed
6/14/2023, 05:48 PM
Previous filing
Jun 12, 2023
Next filing
Jul 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Sale -$114K -1.49K -4.81% $76.90 29.4K Jun 13, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on November 30, 2022.